ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 268 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $682,500 | -12.1% | 42,000 | 0.0% | 0.19% | +3.9% |
Q1 2024 | $776,580 | -40.9% | 42,000 | 0.0% | 0.18% | -39.5% |
Q4 2023 | $1,315,020 | +50.2% | 42,000 | 0.0% | 0.30% | +79.0% |
Q3 2023 | $875,280 | -41.1% | 42,000 | -32.3% | 0.17% | -38.8% |
Q2 2023 | $1,484,900 | -15.2% | 62,000 | -33.3% | 0.27% | -0.7% |
Q1 2023 | $1,750,260 | – | 93,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $887,684,000 | 7.26% |
Avoro Capital Advisors LLC | 1,630,000 | $56,039,000 | 7.16% |
ACUTA CAPITAL PARTNERS, LLC | 572,756 | $19,691,000 | 4.67% |
HWG Holdings LP | 100,994 | $3,472,000 | 4.38% |
HARVEY CAPITAL MANAGEMENT INC | 230,350 | $7,919,000 | 3.56% |
SECTORAL ASSET MANAGEMENT INC | 671,113 | $23,073,000 | 2.70% |
Palo Alto Investors LP | 1,590,430 | $54,679,000 | 2.58% |
Ghost Tree Capital, LLC | 350,000 | $12,033,000 | 2.24% |
GARRISON BRADFORD & ASSOCIATES INC | 72,550 | $2,494,000 | 2.20% |
EMORY UNIVERSITY | 56,135 | $1,930,000 | 1.82% |